Cadherins E and P expression in the molecular types of breast cancer

被引:0
作者
Fernandez, Angel
Reigosa, Aldo
Caleiras, Eduardo [1 ]
Saldivia, Felipe [2 ]
Hardisson, David [3 ]
Sanz, Francisco [4 ]
机构
[1] Hosp Metropolitano Norte, Unidad Diagnost Anatomopatol, Valencia, Venezuela
[2] Inst Oncol Dr Miguel Perez Carreno, Valencia, Venezuela
[3] Univ Autonoma Madrid, Fac Med, Dept Anat Patol, E-28049 Madrid, Spain
[4] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, E-28049 Madrid, Spain
来源
INVESTIGACION CLINICA | 2015年 / 56卷 / 02期
关键词
cadherin E; cadherin P; molecular class; epithelial-mesenchymal transition; breast cancer; EPITHELIAL-MESENCHYMAL TRANSITION; BASAL-LIKE PHENOTYPE; ESTROGEN-RECEPTOR; TUMOR PROGRESSION; STEM-CELLS; SUBTYPES; CARCINOMA; THERAPY; PROGNOSIS; SURVIVAL;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The epithelial-mesenchymal transition is a process by which tumor cells lose their epithelial markers and migrate to distant organs. This process involves several cell adhesion proteins such as E-cadherin and P-cadherin. The present study was performed in 354 pacients diagnosed with breast infiltrating ductal carcinoma in the Oncology Institute "Dr. Miguel Perez Carrerno", Valencia, Venezuela. The expression of 22 molecules was analyzed by tissue micro-arrays and the results were compared with the molecular clases established by immunohistochemistry, according to the expression of estrogen receptor (ER), progesterone (PR) and human epidermal growth factor receptor type 2 (HER2), and with the overall survival (OS). Based on the results of ER, PR and HER2 molecular classes according to the following percentages were established: Luminal A 42.4%, Luminal B 20.3%, 9% HER2 and 28.2% triple negative (TN). E-cadherin expression was observed conserved in most of the tumors of this series, 92.5% of cases. TN phenotype tumors showed a high percentage (41.7%) with absent or reduced expression. The P-cadherin was expressed in 40.5% of cases, although expressed in all classes; the proportion was significantly higher in cases TN. No significant prognostic value was observed when analyzing the overall five-year survival of patients with tumors with absent or reduced expression of E-cadherin. The P-cadherin expression had a negative relationship with the OS.
引用
收藏
页码:155 / 168
页数:14
相关论文
共 50 条
[31]   Immunoexpression of E-, P- and N-cadherins in ovarian serous malignant tumors [J].
Dochit, Corina Maria ;
Stepan, Alex Emilian ;
Margaritescu, Claudiu ;
Florescu, Mirela Marinela ;
Simionescu, Cristiana Eugenia .
ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2019, 60 (04) :1215-1219
[32]   Molecular Taxonomy and Signatures of Breast Cancer in 2017 [J].
Joyon, N. ;
Penault-Llorca, F. ;
Lacroix-Triki, M. .
ONCOLOGIE, 2017, 19 (3-4) :64-70
[33]   Relationships between androgen receptor expression and clinicopathological parameters in male breast cancer [J].
Ucak, Ramazan ;
Tanik, Canan ;
Kaya, Cemal ;
Bozkurt, Emre ;
Kabukcuoglu, Fevziye .
ANNALI ITALIANI DI CHIRURGIA, 2022, 93 (01) :40-47
[34]   MicroRNA expression profiling of endocrine sensitive and resistant breast cancer cell lines [J].
Khajah, Maitham A. ;
Al-Ateyah, Alyaa ;
Luqmani, Yunus A. .
BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2022, 31
[35]   Elevated CCL20 expression was associated with poor prognosis for breast cancer [J].
Zhao, Xia ;
Li, Yanping ;
Feng, Yu ;
Lv, Shuzhen .
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2025, 88 (06) :469-480
[36]   Prognostic value of cyclin E expression in breast cancer: a meta-analysis [J].
Gao, Sheng ;
Ma, Jing-Jing ;
Lu, Cheng .
TUMOR BIOLOGY, 2013, 34 (06) :3423-3430
[37]   Significance of E-cadherin expression in triple-negative breast cancer [J].
Kashiwagi, S. ;
Yashiro, M. ;
Takashima, T. ;
Nomura, S. ;
Noda, S. ;
Kawajiri, H. ;
Ishikawa, T. ;
Wakasa, K. ;
Hirakawa, K. .
BRITISH JOURNAL OF CANCER, 2010, 103 (02) :249-255
[38]   The expression of osteopontin in breast cancer tissue and its relationship with p21ras and CD44V6 expression [J].
Gao, Y. L. ;
Xing, L. Q. ;
Ren, T. J. ;
Hau, J. F. ;
Xue, Q. ;
Liu, C. ;
Han, Y. M. .
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2016, 37 (01) :41-47
[39]   E-cadherin expression in invasive breast cancer [J].
Suciu, C. ;
Cimpean, Anca Maria ;
Muresan, Anca Maria ;
Izvernariu, D. ;
Raica, M. .
ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2008, 49 (04) :517-523
[40]   Patterns and Biologic Features of p53 Mutation Types in Korean Breast Cancer Patients [J].
Kim, Hyung Won ;
Lee, Hak Min ;
Hwang, Seung Hyun ;
Alm, Sung Gwe ;
Lee, Kyung-A ;
Jeong, Joon .
JOURNAL OF BREAST CANCER, 2014, 17 (01) :1-7